期刊文献+

COVID-19 and cardiovascular diseases 被引量:3

原文传递
导出
摘要 The coronavirus disease 2019(COVID-19)remains a global public health emergency.Despite being caused by severe acute respiratory syndrome coronavirus 2(SARS-CoV-2),besides the lung,this infectious disease also has severe implications in the cardiovascular system.In this review,we summarize diverse clinical complications of the heart and vascular system,as well as the relevant high mortality,in COVID-19 patients.Systemic inflammation and angiotensin-converting enzyme 2-involved signaling networking in SARS-CoV-2 infection and the cardiovascular system may contribute to the manifestations of cardiovascular diseases.Therefore,integration of clinical observations and experimental findings can promote our understanding of the underlying mechanisms,which would aid in identifying and treating cardiovascular injury in patients with COVID-19 appropriately.
出处 《Journal of Molecular Cell Biology》 SCIE CAS CSCD 2021年第3期161-167,共7页 分子细胞生物学报(英文版)
基金 supported by grants from the National Key Research and Development Program of China(2018YFA0800200 and 2018YFA0801200) the Strategic Priority Research Program of the Chinese Academy of Sciences(XDA16010207) the National Natural Science Foundation of China(31830061,31425016,and 81530004) supported by the State Key Laboratory of Membrane Biology of China.
  • 相关文献

参考文献5

二级参考文献67

  • 1Jin HY. Song B, Oudit GY. Davidge ST. Yu HM. Jiang YY. Gao PJ. Zhu DL. Ning G. Kassiri Z. Penninger JM. Zhong rc. ACE2 deficiency enhances angiotensin II-mediated aortic profilin-l expression. intlammalion and peroxynilrite production. PLoS ONE. 2012. 7: e38502.
  • 2Sato T. Suzuki T. Watanabe H. Kadowaki A. Fukamizu A. Liu PP. Kimura A. Ito H. Penninger JM. Imai Y. Kuba K. Apelin is a positive regulator of ACE2 in failing hearts. J Clin Invest. 2013. 123: 5203-5211.
  • 3Schiffrin EL. Vascular remodeling in hypertension: mechanisms and treatment. Hypertension. 2012. 59: 367-374.
  • 4Patel VB. Bodiga S. Basu R. Das SK. Wang W. Wang Z. Lo J. Grant MB. Zhong J. Kassiri Z. Oudit GY. Loss of angiotensin-converting enzyme-2 exacerbates diabetic cardiovascular complications and leads to systolic and vascular dysfunction: a critical role of the angiotensin llIATI receptor axis. Circ Res. 2012. I JO: 1322-1335.
  • 5Heeneman S. Sluimer JC, Daemen MJ. Angiotensin-converting enzyme and vascular remodeling. Circ Res. 2007.101: 441-454.
  • 6Song B. Jin H, Yu X. Zhang Z. Yu H. Ye J. Xu Y. Zhou T. Oudit GY. Ye JY. Chen C. Gao P. Zhu D. Penninger JM. Zhong rc. Angiotensin-converting enzyme 2 attenuates oxidative stress and VSMC proliferation via the JAK2/STAT3/S0CS3 and profilin-I/MAPK signaling pathways. Regul Pept, 2013.185: 44-51.
  • 7Schiffrin EL. Touyz RM. From bedside to bench to bedside: role of renin-angiotensin-aldosterone system in remodeling of resistance arteries in hypertension. Am 1 Physiol Heart Circ Physiol, 2004, 287: H435-446.
  • 8Zhong lC. Huang Y. Yung LM. Lau CW, Leung FP. Wong WT. Lin SG. Yu XV. The novel peptide apelin regulates intrarenal artery tone in diabetic mice. Regul Pept, 2007,144: 109-114.
  • 9Bodiga S. Zhong JC, Wang W. Basu R. Lo J. Liu GC, Guo D. Hol- land SM. Scholey JW. Penninger JM. Kassiri Z. Oudit GY. Enhanced susceptibility to biomechanical stress in ACE2 null mice is prevented by loss of the p47(phox) NADPH oxidase subunit. Cardiovasc Res. 2011.91: 151-161.
  • 10Zhong J. Guo D. Chen CB. Wang W. Schuster M. Loibner H. Penninger JM. Scholey JW. Kassiri Z. Oudit GY. Prevention of angiotensin II-mediated renal oxidative stress. inflammation and fibrosis by angiotensin-converting enzyme 2. Hypertension. 2011. 57: 314-322.

共引文献644

同被引文献7

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部